Work

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study

Year: 2021

Type: article

Abstract: Rare Thromboembolic Events among Vaccinated South Africans Among 288,368 South African health care workers who received the Ad26.COV2.S vaccine, no cases of vaccine-induced immune thrombotic thromb...

Source: New England Journal of Medicine

DOI: 10.1056/nejmc2107920

Authors: Simbarashe Takuva, Azwidhwi Takalani, Nigel Garrett, Ameena Goga, Jonny Peter, Vernon Louw, Jessica Opie, Barry Jacobson, Ian Sanne, Linda Gail-Bekker, Glenda Gray

Institutions: Fred Hutch Cancer Center, Centre for the AIDS Programme of Research in South Africa, South African Medical Research Council, University of Cape Town, University of the Witwatersrand, Right to Care

Language: English

Topic: Heparin-Induced Thrombocytopenia and Thrombosis

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: South African Medical Research Council, Johnson and Johnson, National Institute of Allergy and Infectious Diseases

Awards: Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication, KwaZulu-Natal Clinical Trials Unit

OpenAlex ID: W3164587779

FWCI: 7.934

Cites: 2

Cited by: 50

Related to: 10